LDFVX
Price
$15.67
Change
+$0.15 (+0.97%)
Updated
Jun 26 closing price
Net Assets
1.94B
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

LDFVX vs RMEBX

Header iconLDFVX vs RMEBX Comparison
Open Charts LDFVX vs RMEBXBanner chart's image
Lord Abbett Fundamental Equity A
Price$15.67
Change+$0.15 (+0.97%)
VolumeN/A
Net Assets1.94B
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
LDFVX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LDFVX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LDFVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. LDFVX (1.94B). RMEBX pays higher dividends than LDFVX: RMEBX (1.16) vs LDFVX (0.82). LDFVX was incepted earlier than RMEBX: LDFVX (29 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than LDFVX (0.95). LDFVX is a more actively managed with annual turnover of: 39.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than LDFVX: RMEBX (250) vs LDFVX (1500). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. LDFVX (6.41). RMEBX (62.71) and LDFVX (60.42) have equivalent 5 years return.
LDFVXRMEBXLDFVX / RMEBX
Total Expense Ratio0.951.0789%
Annual Report Gross Expense Ratio0.951.0789%
Fund Existence29 years11 years-
Gain YTD2.9867.31541%
Front Load6%N/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets1.94B106B2%
Annual Yield % from dividends0.821.1671%
Returns for 1 year6.419.5068%
Returns for 3 years32.5025.88126%
Returns for 5 years60.4262.7196%
Returns for 10 years23.3474.5131%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp